BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23053947)

  • 1. miR-499 rs3746444 polymorphism is associated with cancer development among Asians and related to breast cancer susceptibility.
    Chen P; Zhang J; Zhou F
    Mol Biol Rep; 2012 Dec; 39(12):10433-8. PubMed ID: 23053947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between three functional microRNA polymorphisms (miR-499 rs3746444, miR-196a rs11614913 and miR-146a rs2910164) and breast cancer risk: a meta-analysis.
    Zhang H; Zhang Y; Yan W; Wang W; Zhao X; Ma X; Gao X; Zhang S
    Oncotarget; 2017 Jan; 8(1):393-407. PubMed ID: 27880723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five common functional polymorphisms in microRNAs (rs2910164, rs2292832, rs11614913, rs3746444, rs895819) and the susceptibility to breast cancer: evidence from 8361 cancer cases and 8504 controls.
    Dai ZJ; Shao YP; Wang XJ; Xu D; Kang HF; Ren HT; Min WL; Lin S; Wang M; Song ZJ
    Curr Pharm Des; 2015; 21(11):1455-63. PubMed ID: 25483824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An A/G polymorphism rs3746444 in miR-499 is associated with increased cancer risk: a meta-analysis.
    Wang N; Tian ZQ; Li Y; Zhou RM; Wang GY
    Genet Mol Res; 2013 Sep; 12(3):3955-64. PubMed ID: 24085457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of the association between microRNA-499 rs3746444 A/G polymorphism and cancer risk.
    Sun H; Li Q; Yang T; Wang W
    Tumour Biol; 2014 Mar; 35(3):2351-8. PubMed ID: 24258110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis.
    Tan SC; Lim PY; Fang J; Mokhtar MFM; Hanif EAM; Jamal R
    Sci Rep; 2020 Feb; 10(1):3508. PubMed ID: 32103099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of common polymorphisms rs2910164 in miR-146a and rs3746444 in miR-499 on cancer susceptibility: a meta-analysis.
    Yin Z; Yan L; Cui Z; Li X; Ren Y; Zhou B
    Mol Biol Rep; 2013 Apr; 40(4):3003-13. PubMed ID: 23292097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between common genetic variant of microRNA-499 and cancer susceptibility: a meta-analysis.
    Fan C; Chen C; Wu D
    Mol Biol Rep; 2013 Apr; 40(4):3389-94. PubMed ID: 23271127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between common genetic variant of microRNA-146a and cancer susceptibility.
    Qiu LX; He J; Wang MY; Zhang RX; Shi TY; Zhu ML; Mao C; Sun S; Lv FF; Zheng CL; Zhu XD
    Cytokine; 2011 Dec; 56(3):695-8. PubMed ID: 21978540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between Hsa-Mir-499 rs3746444 polymorphism and cancer risk: meta-analysis findings.
    Jiang SG; Chen L; Tang JH; Zhao JH; Zhong SL
    Asian Pac J Cancer Prev; 2015; 16(1):339-44. PubMed ID: 25640376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the relationship between microRNA-499 rs3746444 polymorphism and hepatocellular carcinoma risk in Asians.
    Wang W; Qin H; Zhou L; Ma J
    J Cancer Res Ther; 2016; 12(2):676-80. PubMed ID: 27461631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of Hsa-mir-499 polymorphism (rs3746444) for cancer risk: evidence from 31 case-control studies.
    Chen C; Yang S; Chaugai S; Wang Y; Wang DW
    BMC Med Genet; 2014 Nov; 15():126. PubMed ID: 25433484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between miR-499 rs3746444 and the susceptibility of hepatocellular carcinoma.
    Yu H; Wang Y; Wang S; Sun N
    Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):42-5. PubMed ID: 27453271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls.
    Fang F; Yao L; Yu XJ; Yu L; Wu Q; Yu L
    Breast Cancer Res Treat; 2010 Jul; 122(1):267-71. PubMed ID: 20035378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between miR-149 C>T polymorphism and cancer susceptibility: a meta-analysis based on 4,677 cases and 4,830 controls.
    Zhang J; Liu YF; Gan Y
    Mol Biol Rep; 2012 Sep; 39(9):8749-53. PubMed ID: 22714913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies.
    Wang J; Bi J; Liu X; Li K; Di J; Wang B
    Mol Biol Rep; 2012 Apr; 39(4):4571-9. PubMed ID: 21947843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-499 rs3746444 polymorphism and hepatocellular carcinoma risk: A meta-analysis.
    Qiu D; Han F; Zhuang H
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S490-S493. PubMed ID: 29970712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of two inflammation-related polymorphisms with susceptibility to hepatocellular carcinoma: a meta-analysis.
    Liu J; Xie B; Chen S; Jiang F; Meng W
    BMC Med Genet; 2014 Aug; 15():92. PubMed ID: 25108400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls.
    Wang F; Sun G; Zou Y; Li Y; Hao L; Pan F
    PLoS One; 2012; 7(9):e45042. PubMed ID: 22970328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-miR-27a rs895819A/G polymorphisms in cancer: a meta-analysis.
    Xu Q; He CY; Liu JW; Yuan Y
    PLoS One; 2013; 8(6):e65208. PubMed ID: 23762318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.